Tempest Therapeutics (TPST)
Nasdaq • TPST • US87978U2078
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 27, 2026, ORTEX estimated 2.6% of free float sold short, 1.1 days to cover, cost to borrow 23.31%. Sign up for live short interest data.
Market Cap
6.19m USD | # 11735 in US
Volume
2.54m shares | 2.03m USD
Shares Outstanding
16.54m
Free Float Shares
69.27% | 11.46m
